PARP1 and neoplasm: BRCA1- or BRCA2- deficient tumor cells were shown to be highly sensitive to pharmaceutical inhibition of poly (ADP-ribose) polymerase 1 (PARP1), a protein involved in the repair of single-strand DNA breaks (SSBs) (Bryant et al., 2005; Farmer et al., 2005).